Gee, we may be headed for some clinical results the naysayers won't want to see.
As for your invitation to post on IV, Aeinstein, I went there this morning and signed up, but only saw two posts under MSON. Perhaps I haven't figured out how to navigate the site yet, or people have grown more comfortable with using the Yahoo board. In any event, I don't think we'll ever locate that utopia in which the a*holes will have been left behind.
Here's something to ponder. Once MSON does begin manufacturing devices for the US market, won't distribution partner USHIFU have to buy the SB500s outright and then either resell them outright or offer them to sites on a pay-per-procedure basis? And won't it be USHIFU which will raise whatever funding is required to enter the US market? Is there any reason to expect MSON to do anything other than sell the devices outright to USHIFU? Shouldn't this ultimately become an excellent revenue source for MSON. And, for that matter, where does one suppose USHIFU is going to get the devices to be used in the upcoming 24 site US trial?